Skip to content

Clinical Observation of Electroacupuncture at Different Frequencies for Treating Mild Depression in Perimenopausal Women

Clinical Observation of Electroacupuncture at Different Frequencies for Treating Mild Depression in Perimenopausal Women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000146
Enrollment
Unknown
Registered
2026-01-24
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perimenopausal mild depression

Interventions

Group A:Group A received electroacupuncture stimulation at acupoints, with the waveform set to continuous wave and the frequency set to 2Hz
Group B:Group B received electroacupuncture stimulation at acupoints, with the waveform set to continuous wave and the frequency set to 50Hz

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 40 to 60; 2. Within one year of menopause or with a history of menstrual irregularities, presenting typical symptoms of hot flashes and night sweats, which may be accompanied by irritability, palpitations, insomnia, emotional disturbances, memory decline, aching in the lower back and legs, and dyspareunia. 3. Exhibits at least two of the following symptoms: (1) Depressed mood, present for most of the day, nearly every day, largely unaffected by circumstances, lasting at least two weeks; (2) Lack of energy or excessive fatigue; (3) Loss of interest or pleasure in activities that were previously enjoyable 4. Hamilton Depression Rating Scale (HAMD-17) total score =8 and <17; 5. Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1: Assessing suicidal tendencies using the Beck Depression Inventory; 2: Have taken estrogen or selective serotonin reuptake inhibitors within the past 4 weeks; 3: Combined hypertension, renal failure, and other malignant diseases; 4: Implant a pacemaker.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Rating Scale 17-item (HAMD-17) Score;

Secondary

MeasureTime frame
Modified Kupperman Index;Menopause-specific Quality of Life questionnaire;Self-Rating Depression Scale;Self-Rating Anxiety Scale;Heart Rate Variability;

Countries

China

Contacts

Public ContactCong Wang

Guangdong Provincial Hospital of Chinese Medicine

54149376@qq.com13710752416

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026